http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0129409-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5deddb47ccaab1d4da2aacc344dd8717 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 1984-06-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cddc1a5277f9edd81ad0878c3a26327 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c52c76da2649a0e1b84da579505ca3 |
| publicationDate | 1984-12-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0129409-A2 |
| titleOfInvention | Thiazolo - and thiazinobenzimidazoles |
| abstract | This invention relates to pharmaceutical compositions comprising compounds of formulan or a pharmaceutically acceptable saltthereofwherein-B-B 1 - represents a chain of formulan orn orn n R represents an optionally substituted aryl or heteroaryl radical, R', R 2 , R 3 and R 4 independently represent hydrogen, or a defined substituent or any adjacent pair of R', R 2 , R 3 and R 4 together with the carbon atoms to which they are attached complete a five or six membered saturated or unsaturated carbocyclic or heterocyclic ring, said ring being optionally substituted by a defined substituentand said heterocyclic ring having at least one heteroatom selected from oxygen, nitrogen and sulphur; R 5 and R 6 independently represent hydrogen or lower alkyl; n and m independently represent 0 or 1, providing that when -B-B'- has formula la, n is 1 and m is O then R is heteroaryl, the term "heteroaryl" means a monovalent aromatic heterocyclic group in which the ring heteroatom or atoms is/are selected from oxygen, nitrogen and sulphur; and a pharmaceutically acceptable carrier which have anti-uicer and/or anti-secretory activity. Novel compounds of formula I are also disclosed together with processes for preparing them. |
| priorityDate | 1983-06-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 562 of 562.